Results 121 to 130 of about 56,158 (307)
Rheumatic diseases and multimorbidity
Terapevticheskii arkhiv, 2015 In the past decade, investigators' undeniable and justified interest has not been fading in comorbidities in the presence of rheumatic diseases. The terms "comorbidity" and "multimorbidity" are frequently and not always consciously used as interinterchangeable, confusing the terminology and accordingly the elaboration of strategies for further ...
E L Nasonov, A V Gordeev, E A Galushko
openaire +3 more sources
Neurourology and Urodynamics, EarlyView.ABSTRACT Aims Urinary incontinence (UI) is a prevalent condition among adults and imposes a substantial societal burden, yet its association with all‐cause mortality remains uncertain. This study systematically reviewed and quantified the association between UI and mortality risk.
Yanyan Zhou +6 more
wiley +1 more source
Prevalence of Multimorbidity in Lithuania: Insights from National Health Insurance Fund Data
Journal of Cardiovascular Development and Disease(1) Background: As the burden of multimorbidity is increasing worldwide, little is known about its prevalence in Lithuania. We aimed to estimate the prevalence of chronic conditions and multimorbidity among Lithuanian adults and assess their impact on ...
Dovilė Ramanauskaitė +3 more
doaj +1 more source
Multimorbidity in rheumatic conditions [PDF]
Wiener klinische Wochenschrift, 2016 In recent years, multimorbidity in rheumatic conditions has gained increasing attention. Rheumatologist care for an aging patient population with multiple diseases, therefore multimorbidity is the rule, not the exception. Owing to the high prevalence and the potential interaction of coexisting diseases, multimorbidity needs to be taken into account ...
openaire +2 more sources
Neuroprotection, EarlyView.Epilepsy: Global Trends and the Chinese Experience (1990–2021). The infographic depicts (left) the global distribution of age‐standardized epilepsy DALY rates; (center) the triple inequality gap within China, including regional mortality disparities (9‐fold difference between western and eastern provinces), urban‐rural treatment gaps (60%–90%), and ...
Ting Chen +7 more
wiley +1 more source
Obesity, EarlyView.ABSTRACT Objective This study aimed to evaluate the association of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) with risks of osteoporosis, major osteoporotic fractures, and degenerative musculoskeletal disorders in nondiabetic adults with obesity compared with other obesity medications.
Jie‐Syuan Wu +5 more
wiley +1 more source
Sex-Specific Multimorbidity–Multibehaviour Patterns in Primary Care Populations [PDF]
Background: A conceptual shift in healthcare emphasises multimorbidity and multibehaviours as interconnected phenomena, highlighting dose–response associations and sex-specific differences.
Spyropoulos, Konstantinos +2 more
core +1 more source
JMIR Public Health and SurveillanceBackgroundMultimorbidity is a crucial factor that influences premature death rates, poor health, depression, quality of life, and use of health care. Approximately one-fifth of the global workforce is involved in shift work, which
Hye Chong Hong, Young Man Kim
doaj +1 more source
Obesity, EarlyView.ABSTRACT Objective SURMOUNT‐REAL UK will evaluate the effectiveness of tirzepatide when offered in addition to standard‐of‐care (SoC) in adults with Class I obesity (BMI ≥ 30 and ≤ 34.9 kg/m2) and without diabetes in a UK primary care setting. Methods A 5‐year, phase 4, multicenter, open‐label, pragmatic randomized clinical trial is enabled through ...
Martin K. Rutter +14 more
wiley +1 more source
Modeling the spectrum and determinants of multimorbidity risk among older adults in India.
PLoS ONEBackgroundIndia is passing through a parallel phase of demographic and epidemiological transition coupled with the shifting burden of multimorbidity. Unhealthy ageing and escalating morbidity burden have been identified as key drivers of this shifting ...
Ajay Kumar, Bharti Singh
doaj +1 more source